Healthcare products company West Pharmaceutical Services (NYSE:WST) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $698 million. The company’s full-year revenue guidance of $2.96 billion at the midpoint came in 2% above analysts’ estimates. Its non-GAAP profit of $1.45 per share was 18.1% above analysts’ consensus estimates.
Looking for the best money market account interest rates available today? Here’s where to find the highest rates. Is a good time to open a money market account?
(Bloomberg) -- One of Wall Street’s biggest bulls is throwing in the towel on expectations for large gains this year, seeing tariffs hitting corporate America the hardest.Most Read from BloombergTrump Gives New York ‘One Last Chance’ to End Congestion FeeWhy Car YouTuber Matt Farah Is Fighting for Walkable CitiesBackyard Micro-Flats Aim to Ease South Africa’s Housing CrisisThe Racial Wealth Gap Is Not Just About MoneyTo Fuel Affordable Housing, This Innovation Fund Targets Predevelopment CostsDe
(Bloomberg) -- In recent days, the wild swings in US stocks, largely driven by President Donald Trump’s repeated U-turns on tariffs, have caused many on Wall Street to throw up their hands in exasperation.Most Read from BloombergTrump Gives New York ‘One Last Chance’ to End Congestion FeeWhy Car YouTuber Matt Farah Is Fighting for Walkable CitiesBackyard Micro-Flats Aim to Ease South Africa’s Housing CrisisThe Racial Wealth Gap Is Not Just About MoneyTo Fuel Affordable Housing, This Innovation F
Carl Raymond Cruz, the new CEO of Globe Telecom, also admits his "bias" for Indian companies, thanks to their "rigor" and "operational intensity."
Since October 2024, MasTec has been in a holding pattern, posting a small loss of 3.6% while floating around $118.18.
In a sliding market, Markforged has defied the odds, trading up to $4.80 per share. Its 6% gain since October 2024 has outpaced the S&P 500’s 8.1% drop. This performance may have investors wondering how to approach the situation.
In a sliding market, Worthington has defied the odds, trading up to $46.92 per share. Its 21.6% gain since October 2024 has outpaced the S&P 500’s 8.1% drop. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Amentum has gotten torched over the last six months - since October 2024, its stock price has dropped 34.1% to $19.75 per share. This might have investors contemplating their next move.
Shareholders of nLIGHT would probably like to forget the past six months even happened. The stock dropped 35.8% and now trades at $6.61. This was partly driven by its softer quarterly results and might have investors contemplating their next move.